Abstract

Acute kidney injury (AKI) is a frequent complication of liver transplantation and is associated with increased mortality. We identified the incidence and modifiable risk factors for AKI after living-donor liver transplantation (LDLT) and constructed risk scoring models for AKI prediction. We retrospectively reviewed 538 cases of LDLT. Multivariate logistic regression analysis was used to evaluate risk factors for the prediction of AKI as defined by the RIFLE criteria (RIFLE = risk, injury, failure, loss, end stage). Three risk scoring models were developed in the retrospective cohort by including all variables that were significant in univariate analysis, or variables that were significant in multivariate analysis by backward or forward stepwise variable selection. The risk models were validated by way of cross-validation. The incidence of AKI was 27.3% (147/538) and 6.3% (34/538) required postoperative renal replacement therapy. Independent risk factors for AKI by multivariate analysis of forward stepwise variable selection included: body-mass index >27.5 kg/m2 [odds ratio (OR) 2.46, 95% confidence interval (CI) 1.32–4.55], serum albumin <3.5 mg/dl (OR 1.76, 95%CI 1.05–2.94), MELD (model for end-stage liver disease) score >20 (OR 2.01, 95%CI 1.17–3.44), operation time >600 min (OR 1.81, 95%CI 1.07–3.06), warm ischemic time >40 min (OR 2.61, 95%CI 1.55–4.38), postreperfusion syndrome (OR 2.96, 95%CI 1.55–4.38), mean blood glucose during the day of surgery >150 mg/dl (OR 1.66, 95%CI 1.01–2.70), cryoprecipitate > 6 units (OR 4.96, 95%CI 2.84–8.64), blood loss/body weight >60 ml/kg (OR 4.05, 95%CI 2.28–7.21), and calcineurin inhibitor use without combined mycophenolate mofetil (OR 1.87, 95%CI 1.14–3.06). Our risk models performed better than did a previously reported score by Utsumi et al. in our study cohort. Doses of calcineurin inhibitor should be reduced by combined use of mycophenolate mofetil to decrease postoperative AKI. Prospective randomized trials are required to address whether artificial modification of hypoalbuminemia, hyperglycemia and postreperfusion syndrome would decrease postoperative AKI in LDLT.

Highlights

  • Acute kidney injury (AKI) has been reported to be a frequent complication after orthotopic liver transplantation (LT) which is associated with poor graft survival and increased mortality [1,2,3,4,5,6]

  • Three risk scoring models were developed in the retrospective cohort by including all variables that were significant in univariate analysis (Model 1), or variables that were significant in stepwise multivariate analysis by backward stepwise variable selection (Model 2), or forward stepwise variable selection (Model 3) with a significance criterion of p

  • Clinical risk-scoring models were developed by using odds ratio of predictors that were significant in univariate analysis, variables that were significant in stepwise multivariate analysis by backward stepwise variable selection (Model 2), or forward stepwise variable selection (Model 3)

Read more

Summary

Introduction

Acute kidney injury (AKI) has been reported to be a frequent complication after orthotopic liver transplantation (LT) which is associated with poor graft survival and increased mortality [1,2,3,4,5,6]. A number of studies have evaluated AKI after LT, the incidence and clinical risk factors are not entirely clear and evidences regarding modifiable risk factors are still lacking. This ambiguity may be explained by the variable definitions used for AKI and different clinical settings used in previous studies [1,2,3,4, 7,8,9]. Most previouslyreported risk factors including longer anhepatic phase [12], intraoperative blood loss [1, 13], and large transfusion amount [3, 8, 15], model for end-stage liver disease (MELD) score [2, 7, 8, 12, 21] are not modifiable

Objectives
Methods
Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.